Business is booming.

Ibadan’s University College Hospital delivers first IVF triplets

By Nneka Nwogwugwu

The University College Hospital, Ibadan, has delivered first In Vitro Fertilization, IVF, triplets.

In a statement by the communication department of the hospital said, ‘’The mother and the babies, all females, are in good condition. “The babies weighed 1.4kg, 2.5kg and 2.4kg respectively.’

The Chief Medical Director of the University College Hospital, Ibadan, Professor Jesse Abiodun Otegbayo, while expressing delight at the delivery of the triplets, enthused that it was another success story for UCH.

Prof. Otegbayo pointed out that the commitment to take UCH to an enviable level had played out with the commencement of the IVF in 2020.

He appreciated the team that took part in the delivery.

Reacting to the development, former Chief Medical Director of the hospital, Professor Abiodun Ilesanmi, praised Professor Otegbayo for not abandoning the IVF project he (Ilesanmi) initiated about 13 years ago.

Father of the triplets, Dr. Kehinde Osiki of the Department of History and Strategic Studies at the University of Lagos was on ground to witness the delivery of the babies.

Dr. Osiki could not hide his joy at the arrival of the babies. He pointed out that Technology has brought relief to problems often attributed to spirituality, saying that instead of people carrying the burden of superstition, they should rather seek scientific solutions to problems.

‘’He encouraged married couples who could not fertilise not to lose hope as solutions abound for all problems. The mother of the triplets works with the Forestry Research Institute of Nigeria, Ibadan.

below content

Quality journalism costs money. Today, we’re asking that you support us to do more. Support our work by sending in your donations.

The donation can be made directly into NatureNews Account below

Guaranty Trust Bank, Nigeria

0609085876

NatureNews Online

Leave a comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More